Loureirin C ameliorates ischemia and reperfusion injury in rats by inhibiting the activation of the TLR4 / NF‐κB pathway and promoting TLR4 degradation

Author:

Xu Jikai12,Liu Jingyu12,Li Qing12,Mi Yan12,Zhou Di3,Wang Jian3,Chen Gang3,Liang Dong4,Li Ning3,Hou Yue12ORCID

Affiliation:

1. College of Life and Health Sciences, National Frontiers Science Center for Industrial Intelligence and Systems Optimization Northeastern University Shenyang China

2. Key Laboratory of Data Analytics and Optimization for Smart Industry, Ministry of Education Northeastern University Shenyang China

3. School of Traditional Chinese Materia Medica, Key Laboratory for TCM Material Basis Study and Innovative Drug Development of Shenyang City Shenyang Pharmaceutical University Shenyang China

4. State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences Guangxi Normal University Guilin China

Funder

Fundamental Research Funds for the Central Universities

Higher Education Discipline Innovation Project

National Natural Science Foundation of China

Liaoning Revitalization Talents Program

Publisher

Wiley

Subject

Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3